Clinical Trials Directory

Trials / Completed

CompletedNCT01914354

Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population

Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity: An Untargeted T Cell Population" (# 859869783).

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
The Cleveland Clinic · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This is an observational multi-center study to determine whether any single immune monitoring test or a combination of tests obtained in the first 6 months after renal transplantation correlates with acute rejection or graft loss in renal allograft recipients receiving commonly used immunosuppressive.

Conditions

Timeline

Start date
2012-02-01
Primary completion
2014-01-01
Completion
2014-06-01
First posted
2013-08-02
Last updated
2016-10-28

Source: ClinicalTrials.gov record NCT01914354. Inclusion in this directory is not an endorsement.

Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population (NCT01914354) · Clinical Trials Directory